MNOV vs MRNA · rev $645.4K vs rev $145.0M
MediciNova Inc (MNOV) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
MediciNova Inc (MNOV) is a biotechnology company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported MNOV revenue for 2026-06-30 was $645.4K. Net income was -$4.9M. MNOV currently screens at market cap $66.0M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
MNOV currently screens at market cap $66.0M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the MNOV and MRNA stock pages for the full models.
Not investment advice.